Invasive candidiasis in children

The prevalence of invasive candidiasis (IC) in pediatric hospitals is from 4,3 to 15,2 per 10,000 hospitalized, in ICU – from 3,5 to 7 cases per 1,000, with HSCT – 2,9%. The average length of stay of a patient in the hospital before the development of IC varies from 21 to 56 days, in the ICU – more...

Full description

Saved in:
Bibliographic Details
Main Authors: N. N. Klimko, O. P. Kozlova
Format: Article
Language:Russian
Published: Journal Infectology 2021-07-01
Series:Журнал инфектологии
Subjects:
Online Access:https://journal.niidi.ru/jofin/article/view/1201
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850043391812829184
author N. N. Klimko
O. P. Kozlova
author_facet N. N. Klimko
O. P. Kozlova
author_sort N. N. Klimko
collection DOAJ
description The prevalence of invasive candidiasis (IC) in pediatric hospitals is from 4,3 to 15,2 per 10,000 hospitalized, in ICU – from 3,5 to 7 cases per 1,000, with HSCT – 2,9%. The average length of stay of a patient in the hospital before the development of IC varies from 21 to 56 days, in the ICU – more than 15 days. Knowledge of risk factors (ICU stay for ≥15 days, use of antibacterial drugs and parenteral nutrition, active malignant neoplasm, etc.) makes it possible to identify patients with a high (10-46%) risk of developing IC. Candida albicans remains the leading causative agent of IC in children, but infections with non-albicans Candida spp. have increased and an increase in the resistance of IC pathogens to azole antimycotics was noted. The main clinical variant of IC in children is candidemia, other forms include the central nervous system, abdominal organs, eyes, heart, bones and joints, kidneys, skin and subcutaneous tissue involvement, as well as chronic disseminated (hepatolienal) candidiasis. Blood culture, the main method of laboratory diagnostics of IC, is characterized by low sensitivity and requires a long time. Methods of noncultural diagnostics of IC (1,3-β-D-glucan, mannan and antimannan antibodies, T2 Candida etc) in children have not been sufficiently studied. The main drugs for the treatment of IC in children are echinocandins (anidulafungin, etc.), and CVC removal/replacement is necessary. The overall mortality rate in pediatric patients within 30 days after the diagnosis of IC is 37% to 44%.
format Article
id doaj-art-5dd0a96d3f3847a7b1d0d0fbe5f7d76b
institution DOAJ
issn 2072-6732
language Russian
publishDate 2021-07-01
publisher Journal Infectology
record_format Article
series Журнал инфектологии
spelling doaj-art-5dd0a96d3f3847a7b1d0d0fbe5f7d76b2025-08-20T02:55:14ZrusJournal InfectologyЖурнал инфектологии2072-67322021-07-01132142610.22625/2072-6732-2021-13-2-14-26904Invasive candidiasis in childrenN. N. Klimko0O. P. Kozlova1North-West State Medical University named after I.I. MechnikovNorth-West State Medical University named after I.I. MechnikovThe prevalence of invasive candidiasis (IC) in pediatric hospitals is from 4,3 to 15,2 per 10,000 hospitalized, in ICU – from 3,5 to 7 cases per 1,000, with HSCT – 2,9%. The average length of stay of a patient in the hospital before the development of IC varies from 21 to 56 days, in the ICU – more than 15 days. Knowledge of risk factors (ICU stay for ≥15 days, use of antibacterial drugs and parenteral nutrition, active malignant neoplasm, etc.) makes it possible to identify patients with a high (10-46%) risk of developing IC. Candida albicans remains the leading causative agent of IC in children, but infections with non-albicans Candida spp. have increased and an increase in the resistance of IC pathogens to azole antimycotics was noted. The main clinical variant of IC in children is candidemia, other forms include the central nervous system, abdominal organs, eyes, heart, bones and joints, kidneys, skin and subcutaneous tissue involvement, as well as chronic disseminated (hepatolienal) candidiasis. Blood culture, the main method of laboratory diagnostics of IC, is characterized by low sensitivity and requires a long time. Methods of noncultural diagnostics of IC (1,3-β-D-glucan, mannan and antimannan antibodies, T2 Candida etc) in children have not been sufficiently studied. The main drugs for the treatment of IC in children are echinocandins (anidulafungin, etc.), and CVC removal/replacement is necessary. The overall mortality rate in pediatric patients within 30 days after the diagnosis of IC is 37% to 44%.https://journal.niidi.ru/jofin/article/view/1201anidulafungincandidaechinocandinsinvasive candidiasis
spellingShingle N. N. Klimko
O. P. Kozlova
Invasive candidiasis in children
Журнал инфектологии
anidulafungin
candida
echinocandins
invasive candidiasis
title Invasive candidiasis in children
title_full Invasive candidiasis in children
title_fullStr Invasive candidiasis in children
title_full_unstemmed Invasive candidiasis in children
title_short Invasive candidiasis in children
title_sort invasive candidiasis in children
topic anidulafungin
candida
echinocandins
invasive candidiasis
url https://journal.niidi.ru/jofin/article/view/1201
work_keys_str_mv AT nnklimko invasivecandidiasisinchildren
AT opkozlova invasivecandidiasisinchildren